RITEDOSE PHARMACEUTICALS
LIVE

Serial Number

90136326

Owner

THE RITEDOSE CORPORATION

First Use Date

Feb 1, 2012

Filing Date

Aug 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RITEDOSE PHARMACEUTICALS Trademark

Serial Number: 90136326 • Registration: 6854964

RITEDOSE PHARMACEUTICALS is a trademark filed by THE RITEDOSE CORPORATION on August 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

THE RITEDOSE CORPORATION (25 trademarks)

1 TECHNOLOGY CIRCLE
COLUMBIA, SC 29203

Entity Type: 03

Trademark Details

Filing Date

August 25, 2020

Registration Date

September 27, 2022

First Use Anywhere

February 1, 2012

First Use in Commerce

February 1, 2012

Published for Opposition

September 14, 2021

Goods & Services

Pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 1, 2025 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTICE OF REINSTATEMENT E-MAILED
Aug 26, 2022 MREI
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 25, 2022 DP1B
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Aug 25, 2022 RGIA
ASSIGNED TO PETITION STAFF
Aug 22, 2022 APET
TEAS REQUEST FOR REINSTATEMENT
Aug 12, 2022 ERRS
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 13, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 13, 2022 ABN6
NOTICE OF ALLOWANCE CANCELLED
May 9, 2022 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 9, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 14, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 11, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 11, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 11, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 11, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2021 CRFA
ASSIGNED TO LIE
Jul 26, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Jul 19, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2021 TROA
PETITION TO REVIVE-GRANTED
Jul 19, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 19, 2021 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 12, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 12, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 29, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 29, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 29, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2020 NWOS
NEW APPLICATION ENTERED
Aug 28, 2020 NWAP